"Anaphylaxis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.
| Descriptor ID |
D000707
|
| MeSH Number(s) |
C20.543.480.099
|
| Concept/Terms |
Anaphylaxis- Anaphylaxis
- Shock, Anaphylactic
- Anaphylactic Shock
- Anaphylactic Reaction
- Anaphylactic Reactions
- Reaction, Anaphylactic
- Reactions, Anaphylactic
|
Below are MeSH descriptors whose meaning is more general than "Anaphylaxis".
Below are MeSH descriptors whose meaning is more specific than "Anaphylaxis".
This graph shows the total number of publications written about "Anaphylaxis" by people in this website by year, and whether "Anaphylaxis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 32 | 5 | 37 |
| 2018 | 49 | 8 | 57 |
| 2019 | 25 | 6 | 31 |
| 2020 | 6 | 2 | 8 |
| 2021 | 43 | 5 | 48 |
To return to the timeline, click here.
Below are the most recent publications written about "Anaphylaxis" by people in Profiles.
-
Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA. 2021 10 12; 326(14):1390-1399.
-
High anaphylaxis rates following vaccination with the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers: a secondary analysis of initial post-approval safety data. J Travel Med. 2021 10 11; 28(7).
-
Anaphylaxis and Coronavirus Disease 2019 vaccine: a danger relationship? Curr Opin Allergy Clin Immunol. 2021 10 01; 21(5):411-417.
-
Anaphylaxis and digital medicine. Curr Opin Allergy Clin Immunol. 2021 10 01; 21(5):448-454.
-
Immunization practices and risk of anaphylaxis: a current update, comprehensive of COVID-19 vaccination data. Curr Opin Allergy Clin Immunol. 2021 10 01; 21(5):418-425.
-
Management of anaphylaxis due to COVID-19 vaccines in the elderly. Allergy. 2021 10; 76(10):2952-2964.
-
IgE-mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to mRNA COVID-19 vaccines. Clin Exp Allergy. 2022 01; 52(1):10-11.
-
Cardiopulmonary resuscitation in special circumstances. Lancet. 2021 10 02; 398(10307):1257-1268.
-
Management of anaphylaxis in children undergoing oral food challenges in an adapted COVID-19 field hospital. Arch Dis Child. 2021 12; 106(12):e52.
-
Omalizumab prevents anaphylactoid reactions to mRNA COVID-19 vaccine. J Eur Acad Dermatol Venereol. 2021 Nov; 35(11):e743-e745.